Description
Pharmacological class: Antiretroviral agent for combination therapy protocols.
Mechanism of action:
Interferes with key stages of the retroviral replication cycle, contributing to the reduction of viral load. Designed to act synergistically with immunomodulators and other antiretroviral compounds, supporting a multi-target therapeutic approach and improving overall clinical response.
Maximum recommended dose:
To be defined according to veterinary prescription and patient-specific protocol.
Dosage frequency:
According to combination therapy protocol and veterinary indication.
Adverse effects:
Adverse effects are based on clinical observations in feline patients and extrapolated data from antiretroviral therapies.
When used within recommended protocols and under veterinary supervision, Anti-R2 has shown good tolerability.
In field experience, no significant adverse effects have been reported when administered at appropriate doses and in combination protocols.
Indications:
-
Feline retroviral infections (e.g., FeLV)
-
Cases with persistent viral load
-
Patients with partial or poor response to monotherapy
-
Complex or advanced clinical scenarios
Important:
This product is intended to be used as part of a combination antiretroviral therapy protocol, not as a standalone treatment.
Storage:
-
Store at room temperature
-
Keep away from direct sunlight
Disclaimer:
For veterinary use only.
Use under supervision of a licensed veterinarian.
Availability may vary by country. Please confirm before purchase.
Phoenix does not accept returns, refunds, or exchanges once the purchase has been completed.
